MyAverix Finance
US · Healthcare
CG Oncology, Inc. Common stock (CGON)
Biotechnology
CG Oncology, Inc. Common stock (CGON) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CGON
CG Oncology, Inc. Common stock (CGON) — FAQ
What is CGON's P/E ratio?
The price-to-earnings (P/E) ratio for CG Oncology, Inc. Common stock (CGON) is 18.00 (data as of 2026-03-23).
Does CG Oncology, Inc. Common stock pay a dividend?
Dividend yield is not available in the current snapshot for CG Oncology, Inc. Common stock (CGON). Check the MyAverix Finance app for the latest dividend data.
What sector is CG Oncology, Inc. Common stock in?
CG Oncology, Inc. Common stock (CGON) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CGON listed on?
CGON is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.